How has been the historical performance of Niva Bupa Health?

Answer:The historical performance of Niva Bupa Health shows significant growth in its financial metrics from March 2024 to March 2025.

Breakdown:
In the standalone annual results, Niva Bupa Health reported net sales of 4,894.46 Cr in March 2025, up from 3,811.25 Cr in March 2024, indicating a strong revenue increase. Other operating income also rose to 479.82 Cr from 304.22 Cr, leading to a total operating income of 5,374.28 Cr, compared to 4,115.47 Cr the previous year. Total expenditure, excluding depreciation, increased to 5,316.18 Cr from 4,254.40 Cr, primarily driven by higher manufacturing expenses, which grew from 3,000.37 Cr to 4,061.10 Cr. Despite the increase in expenses, the operating profit (PBDIT) improved significantly to 213.52 Cr from 81.85 Cr, with a notable shift in the operating profit margin from -3.65% to 1.19%. Profit before tax and profit after tax both reached 213.52 Cr, up from 81.85 Cr in the prior year, resulting in an earnings per share (EPS) of 1.17, compared to 0.48. The PAT margin also improved from 2.15% to 4.36%. In terms of cash flow, cash flow from operating activities increased to 812.00 Cr from 592.00 Cr, while cash flow from investing activities showed a larger outflow of -1,881.00 Cr compared to -829.00 Cr in the previous year. The net cash inflow remained positive at 40.00 Cr, slightly down from 43.00 Cr. Overall, the financial performance of Niva Bupa Health demonstrates a positive trend with improved profitability and operational efficiency.